Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability

Molecular Microbiology

Volumn 54, Issue 5, 2004, Pages 1161-1172

  Veyron Churlet, Romain ^a   Guerrini, Olivier ^a   Mourey, Lionel ^a   Daffé, Mamadou ^a   Zerbib, Didier ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE 2; ISONIAZID; MYCOLIC ACID; NEW DRUG; OXIDOREDUCTASE; PROTEIN INHA; PROTEIN KASA; PROTEIN KASB; PROTEIN MABA; PROTEIN MTFABH; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BIOSYNTHESIS; DRUG DESIGN; DRUG TARGETING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MODEL; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE; ACETYLTRANSFERASES; BACTERIAL PROTEINS; GENETIC COMPLEMENTATION TEST; IMMUNOPRECIPITATION; MODELS, MOLECULAR; MULTIENZYME COMPLEXES; MUTAGENESIS, SITE-DIRECTED; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POINT MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TWO-HYBRID SYSTEM TECHNIQUES;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 9644257517     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2004.04334.x     Document Type: Article

References (45)

1. Anonymous (2000) The WHO/IUALTD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization.
2. Anonymous (2002) Stop TB Reports WHO/CDS/STB/2002.17. Geneva: World Health Organization.
3. Asselineau, C., Asselineau, J., Laneelle, G., and Laneelle, M.A. (2002) The biosynthesis of mycolic acids by Mycobacteria: current and alternative hypotheses. Prog Lipid Res 41: 501-523.
4. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
5. Banerjee, A., Sugantino, M., Sacchettini, U.C., and Jacobs, W.R., Jr (1998) The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144: 2697-2704.
6. Blum, J.H., Dove, S.L., Hochschild, A., and Mekalanos, J.J. (2000) Isolation of peptide aptamers that inhibit intracellular processes. Proc Natl Acad Sci USA 97: 2241-2246.
7. Caponigro, G., Abedi, M.R., Hurlburt, A.P., Maxfield, A., Judd, W., and Kamb, A. (1998) Transdominant genetic analysis of a growth control pathway. Proc Natl Acad Sci USA 95: 7508-7513.
8. Choi, K.H., Kremer, L., Besra, G.S., and Rock, C.O. (2000) Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem 275: 28201-28207.
9. Cohen-Gonsaud, M., Ducasse, S., Hoh, F., Zerbib, D., Labesse, G., and Quemard, A. (2002) Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis. J Mol Biol 320: 249-261.
10. Colas, P., Cohen, B., Jessen, T., Grishina, I., McCoy, J., and Brent, R. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380: 548-550.
11. Daffe, M., and Draper, P. (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39: 131-203.
12. Dessen, A., Quemard, A., Blanchard, J.S., Jacobs, W.R., Jr, and Sacchettini, J.C. (1995) Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267: 1638-1641.
13. Ducasse, S., Cohen-Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Labesse, G., and Quemard, A. (2004) In vitro inhibition of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein reductase MabA from M. tuberculosis by isoniazid. Antimicrob Agents Chemother 48: 242-249.
14. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262.
15. Edwards, P., Nelsen, J.S., Metz, J.G., and Dehesh, K. (1997) Cloning of the fabF gene in an expression vector and in vitro characterization of recombinant fabF and fabB encoded enzymes from Escherichia coli. FEBS Lett 402: 62-66.
16. Geyer, C.R., Colman-Lerner, A., and Brent, R. (1999) 'Mutagenesis' by peptide aptamers identifies genetic network members and pathway connections. Proc Natl Acad Sci USA 96: 8567-8572.
17. Huang, W., Jia, J., Edwards, P., Dehesh, K., Schneider, G., and Lindqvist, Y. (1998) Crystal structure of beta-ketoacylacyl carrier protein synthase II from E. coli reveals the molecular architecture of condensing enzymes. EMBO J 17: 1183-1191.
18. Kremer, L., Baulard, A., and Besra, G.S. (2000) Genetics of mycolic acid biosynthesis. In Molecular Genetics of Mycobacteria. Hatfull, G., and Jacobs, W.R. (eds). Washington, DC: American Society for Microbiology Press, pp. 173-190.
19. Kremer, L., Dover, L.G., Carrere, S., Nampoothiri, K.M., Lesjean, S., Brown, A.K., et al. (2002) Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. Biochem J 364: 423-430.
20. Kremer, L., Dover, L.G., Morbidoni, H.R., Vilcheze, C., Maughan, W.N., Baulard, A., et al. (2003) Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria. J Biol Chem 278: 20547-20554.
21. Larsen, M.H., Vilcheze, C., Kremer, L., Besra, G.S., Parsons, L., Salfinger, M., et al. (2002) Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and Mycobacterium tuberculosis. Mol Microbiol 46: 453-466.
22. Lei, S., Pulakat, L., and Gavini, N. (1999) Genetic analysis of nif regulatory genes by utilizing the yeast two-hybrid system detected formation of a NifL-NifA complex that is implicated in regulated expression of nif genes. J Bacteriol 181: 6535-6539.
23. Marrakchi, H., Laneelle, G., and Quemard, A. (2000) InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146: 289-296.
24. Marrakchi, H., Ducasse, S., Labesse, G., Montrozier, H., Margeat, E., Emorine, L., et al. (2002) MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II. Microbiology 148: 951-960.
25. Mdluli, K., Sherman, D.R., Mickey, M.J., Kreiswirth, B.N., Morris, S., Stover, C.K., and Barry, C.E., III (1996) Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis 174: 1085-1090.
26. Mdluli, K., Slayden, R.A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., et al. (1998) Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 280: 1607-1610.
27. Norman, T.C., Smith, D.L., Sorger, P.K., Drees, B.L., O'Rourke, S.M., Hughes, T.R., et al. (1999) Genetic selection of peptide inhibitors of biological pathways. Science 285: 591-595.
28. Odriozola, J.M., Ramos, J.A., and Bloch, K. (1977) Fatty acid synthetase activity in Mycobacterium smegmatis. Characterization of the acyl carrier protein-dependent elongating system. Biochim Biophys Acta 488: 207-217.
29. Ovadi, J., Srere, P.A., and Knull, H.R. (2000) Macromolecular compartmentation and channeling. Location-location-location. Int Rev Cytol 192: 255-280.
30. Portevin, D., De Sousa-D'Auria, C., Houssin, C., Grimaldi, C., Chami, M., Daffe, M., and Guilhot, C. (2004) A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci USA 101: 314-319.
31. Rawat, R., Whitty, A., and Tonge, P.J. (2003) The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci USA 100: 13881-13886.
32. Rozwarski, D.A., Vilcheze, C., Sugantino, M., Bittman, R., and Sacchettini, J.C. (1999) Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. J Biol Chem 274: 15582-15589.
33. Sardet, C., LeCam, L., Fabbrizio, E., and Vidal, M. (1997) Oncogenes as transcriptional regulators. In Cell Cycle Regulators of Chromosomal Translocation. Ghysdael, J., and Yaniv, M. (eds). Birkhauser Verlag, pp. 1-63.
34. Scarsdale, J.N., Kazanina, G., He, X., Reynolds, K.A., and Wright, H.T. (2001) Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III. J Biol Chem 276: 20516-20522.
35. Schaeffer, M.L., Agnihotri, G., Volker, C., Kallender, H., Brennan, P.J., and Lonsdale, J.T. (2001) Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 276: 47029-47037.
36. Slayden, R.A., and Barry, C.E., III (2002) The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 82: 149-160.
37. Slayden, R.A., Lee, R.E., and Barry, C.E., III (2000) Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol 38: 514-525.
38. Srere, P.A. (1987) Complexes of sequential metabolic enzymes. Annu Rev Biochem 56: 89-124.
39. Steyn, A.J., Collins, D.M., Hondalus, M.K., Jacobs, W.R., Jr, Kawakami, R.P., and Bloom, B.R. (2002) Mycobacterium tuberculosis WhiBS interacts with RpoV to affect host survival but is dispensable for in vivo growth. Proc Natl Acad Sci USA 99: 3147-3152.
40. Steyn, A.J., Joseph, J., and Bloom, B.R. (2003) Interaction of the sensor module of Mycobacterium tuberculosis H37Rv KdpD with members of the Lpr family. Mol Microbiol 47: 1075-1089.
41. Stover, C.K., de la Cruz, V.F., Fuerst, T.R., Burlein, J.E., Benson, L.A., Bennett, L.T., et al. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460.
42. Velot, C., and Srere, P.A. (2000) Reversible transdominant inhibition of a metabolic pathway. In vivo evidence of interaction between two sequential tricarboxylic acid cycle enzymes in yeast. J Biol Chem 275: 12926-12933.
43. Vilcheze, C., Morbidoni, H.R., Weisbrod, T.R., Iwamoto, H., Kuo, M., Sacchettini, J.C., and Jacobs, W.R., Jr (2000) Inactivation of the inha-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182: 4059-4067.
44. Ye, Q., and Worman, H.J. (1995) Protein-protein interactions between human nuclear lamins expressed in yeast. Exp Cell Res 219: 292-298.
45. Yang, M., Wu, Z., and Fields, S. (1995) Protein-peptide interactions analyzed with the yeast two-hybrid system. Nucleic Acids Res 23: 1152-1156.